SEC Form 425 filed by Perceptive Capital Solutions Corp
$PCSC
Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
– Leading institutional investors commit $240 million through private investment in public equity (PIPE) led by Perceptive Advisors and RA Capital – – Freenome stockholders, PCSC shareholders and PIPE investors will hold shares in the Combined Company that is expected to be listed on Nasdaq under the ticker symbol FRNM – – Business combination is expected to be completed in the first half of 2026 – BRISBANE, Calif. and NEW YORK, Dec. 5, 2025 /PRNewswire/ -- Freenome Holdings, Inc., an early cancer detection company developing blood-based screening tests, and Perceptive Capital Solutions Corp (NASDAQ:PCSC), a special purpose acquisition company (SPAC) sponsored by an affiliate of Perceptive
SCHEDULE 13G - Perceptive Capital Solutions Corp (0002017526) (Subject)
SCHEDULE 13G - Perceptive Capital Solutions Corp (0002017526) (Subject)
SCHEDULE 13D - Perceptive Capital Solutions Corp (0002017526) (Subject)
SC 13G - Perceptive Capital Solutions Corp (0002017526) (Subject)
SC 13G - Perceptive Capital Solutions Corp (0002017526) (Subject)
SC 13G - Perceptive Capital Solutions Corp (0002017526) (Subject)